Stock MODV MODIVCARE INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials ModivCare Inc.

Equities

MODV

US60783X1046

Healthcare Facilities & Services

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-26 pm EDT 		5-day change 1st Jan Change
23.56 USD -1.55% Intraday chart for ModivCare Inc. +10.82% -46.44%
Apr. 03 ModivCare Inc.(NasdaqGS:MODV) dropped from S&P Composite 1500 CI
Apr. 03 ModivCare Inc.(NasdaqGS:MODV) dropped from S&P 600 CI

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 763.4 1,966 2,076 1,269 624.1 334.5 - -
Enterprise Value (EV) 1 702.4 1,966 2,918 2,234 1,761 1,387 1,343 1,276
P/E ratio -228 x 58.5 x -316 x -39.7 x -3.05 x -32.3 x 14 x 8.12 x
Yield - - - - - - - -
Capitalization / Revenue 0.51 x 1.44 x 1.04 x 0.51 x 0.23 x 0.12 x 0.11 x 0.1 x
EV / Revenue 0.47 x 1.44 x 1.46 x 0.89 x 0.64 x 0.5 x 0.45 x 0.4 x
EV / EBITDA 13.7 x 11.6 x 14.2 x 10.3 x 8.85 x 7.29 x 6.09 x 5.12 x
EV / FCF 14 x 5.85 x 17.6 x -51.4 x -14.1 x 38.2 x 21.3 x 13.8 x
FCF Yield 7.13% 17.1% 5.67% -1.95% -7.11% 2.62% 4.69% 7.23%
Price to Book 2.42 x - 5.58 x 3.58 x 3.99 x 1.93 x 1.51 x 1.17 x
Nbr of stocks (in thousands) 12,899 14,184 14,000 14,138 14,187 14,198 - -
Reference price 2 59.18 138.6 148.3 89.73 43.99 23.56 23.56 23.56
Announcement Date 2/27/20 2/26/21 2/25/22 2/23/23 2/22/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 1,510 1,369 1,997 2,504 2,751 2,795 3,004 3,212
EBITDA 1 51.22 169.3 205 215.9 198.9 190.3 220.7 249.4
EBIT 1 24.73 123.2 89.77 57.08 -139.9 66.54 110.5 131.8
Operating Margin 1.64% 9% 4.5% 2.28% -5.09% 2.38% 3.68% 4.1%
Earnings before Tax (EBT) 1 -5.526 114.4 40.69 -4.877 -209.1 -12.6 31.94 54.84
Net income 1 -3.437 32.47 -6.585 -31.81 -204.5 -5.264 27.44 43.57
Net margin -0.23% 2.37% -0.33% -1.27% -7.43% -0.19% 0.91% 1.36%
EPS 2 -0.2600 2.370 -0.4700 -2.260 -14.43 -0.7300 1.683 2.900
Free Cash Flow 1 50.08 336.3 165.5 -43.45 -125.3 36.27 62.98 92.3
FCF margin 3.32% 24.57% 8.29% -1.73% -4.55% 1.3% 2.1% 2.87%
FCF Conversion (EBITDA) 97.78% 198.58% 80.74% - - 19.06% 28.53% 37%
FCF Conversion (Net income) - 1,035.65% - - - - 229.49% 211.83%
Dividend per Share 2 - - - - - - - -
Announcement Date 2/27/20 2/26/21 2/25/22 2/23/23 2/22/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales 1 493.1 575.8 574.5 628.2 647.8 653.9 662.3 699.1 686.9 702.8 663.9 694.2 709.7 727.1 723.6
EBITDA 1 44.32 57.51 48.83 51.66 51.8 57.83 49.38 51.42 49.64 48.49 30.06 44.73 54.41 61.11 46.98
EBIT 1 13.12 20.26 14.87 23.15 12.45 6.617 8.098 -175.8 12.04 15.68 2.578 13.57 21.95 28.44 18.47
Operating Margin 2.66% 3.52% 2.59% 3.68% 1.92% 1.01% 1.22% -25.14% 1.75% 2.23% 0.39% 1.95% 3.09% 3.91% 2.55%
Earnings before Tax (EBT) 1 -11.32 5.593 -0.526 7.674 -3.11 -8.915 -7.86 -192.7 -5.801 -2.675 -16.31 -5.712 1.402 7.976 -2.442
Net income 1 -7.57 -31.53 0.318 3.328 -28.5 -6.947 -3.962 -190.9 -4.302 -5.252 -12.66 -3.645 2.368 8.654 -1.74
Net margin -1.54% -5.48% 0.06% 0.53% -4.4% -1.06% -0.6% -27.31% -0.63% -0.75% -1.91% -0.52% 0.33% 1.19% -0.24%
EPS 2 -0.5400 -2.250 0.0200 0.2400 -2.030 -0.4900 -0.2800 -13.47 -0.3000 -0.3700 -0.9275 -0.3250 0.0325 0.4825 -0.1200
Dividend per Share 2 - - - - - - - - - - - - - - -
Announcement Date 11/5/21 2/25/22 5/5/22 8/4/22 11/3/22 2/23/23 5/4/23 8/3/23 11/2/23 2/22/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - - 842 965 1,137 1,052 1,009 942
Net Cash position 1 61 - - - - - - -
Leverage (Debt/EBITDA) - - 4.108 x 4.468 x 5.717 x 5.53 x 4.569 x 3.777 x
Free Cash Flow 1 50.1 336 166 -43.4 -125 36.3 63 92.3
ROE (net income / shareholders' equity) - - 28.6% 28.4% 31.3% 41.9% 44.2% 44.1%
ROA (Net income/ Total Assets) - - 6.5% 5.21% 4.31% 3.86% 4.8% 6.02%
Assets 1 - - -101.3 -610.8 -4,748 -136.5 572.2 724.1
Book Value Per Share 2 24.50 - 26.60 25.00 11.00 12.20 15.60 20.10
Cash Flow per Share 2 - - 13.30 -0.7400 -5.850 5.810 6.190 8.080
Capex 1 10.9 12.2 21.3 33 42.3 41.6 44.6 46.8
Capex / Sales 0.72% 0.89% 1.07% 1.32% 1.54% 1.49% 1.48% 1.46%
Announcement Date 2/27/20 2/26/21 2/25/22 2/23/23 2/22/24 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for ModivCare Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C-
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
23.56 USD
Average target price
46.6 USD
Spread / Average Target
+97.79%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Healthcare Facilities & Services

1st Jan change Capi.
MODIVCARE INC. Stock ModivCare Inc.
-46.44% 335M
CVS HEALTH CORPORATION Stock CVS Health Corporation
-14.92% 84.68B
HCA HEALTHCARE, INC. Stock HCA Healthcare, Inc.
+13.30% 81.12B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY Stock Dr. Sulaiman Al Habib Medical Services Group Company
+11.62% 29.59B
LABORATORY CORPORATION OF AMERICA HOLDINGS Stock Laboratory Corporation of America Holdings
-12.71% 16.73B
FRESENIUS SE & CO. KGAA Stock Fresenius SE & Co. KGaA
-2.10% 16.36B
QUEST DIAGNOSTICS INCORPORATED Stock Quest Diagnostics Incorporated
-2.63% 14.92B
PURE HEALTH HOLDING Stock Pure Health Holding
-31.40% 11.77B
FRESENIUS MEDICAL CARE AG Stock Fresenius Medical Care AG
-0.11% 11.72B
DAVITA INC. Stock DaVita Inc.
+27.44% 11.71B
Other Healthcare Facilities & Services
  1. Stock Market
  2. Equities
  3. MODV Stock
  4. Financials ModivCare Inc.